Nature’s Solution

I am a regular general veterinary practitioner who has found herself in an exciting situation, where I have been asked to be involved in a new method of treating cancer.

I have no oncology training, but I have certainly seen many animals treated with current chemotherapy and radiation techniques.

The EBC 46 may never replace these proven cancer-fighting methods, however, I believe it will certainly play an important role in the treatment of certain cancers, suffered by not only dogs and cats, but other animals as well.

I was very sceptical when I was first approached regarding running small animal trials. However, my doubts as to the validity of the EBC 46 were squashed almost immediately.

As with all experimental trials, a new drug/compound cannot be trialled on animals with the option of current standard therapies. So, especially in the initial stages of the trial, we were treating on animals that had already had surgery and chemotherapy, and animals that had inoperable tumours. Many were at the end stage of their disease, and the option was either euthanasia or to trial this treatment.

Because of these beginnings, my first impression was the incredible improvement to the quality of life experienced by animals treated with the EBC 46. Not all animals had a significant reduction in tumour size, but nearly all the animals experienced an improved zest for life.

If this was the limit of the EBC 46’s abilities then, with this effect alone, I believe it will play a huge role in palliative care.

However, as the trials went on and more animals were being treated, I was witnessing more and more impressive results.

Whilst I would never say that this is going to cure all cancer, I will say I have seen some incredible, almost unbelievable results.

As cancer is such an emotive issue I feel it is important that it is understood that all cancer-fighting treatments have limitations. At this stage EBC 46 has only been used on cutaneous, sub cutaneous oral, and nasal tumours. We have not treated metastatic (distant) disease, so in these cases it would be used more as a palliative therapy. With the primary masses, the hope is always complete resolution of the tumour, but we consider any improvement in quality of life a success.

My hope is that veterinarians around Australia have the EBC 46 on their drug room shelf by the end of 2011. It would be great to know that we have yet another effective anti-cancer compound available to use in our fight against cancer.

For all those other sceptics (remember I was one initially also), imagine how easy it would have been to discount Fleming and his discovery that mould could be used to kill bacterial infections. Amazing things come from nature.